Are interstitial fluid concentrations of meropenem equivalent to plasma concentrations in critically ill patients receiving continuous renal replacement therapy?
Author(s) -
Julie Varghese,
Paul Jarrett,
Steven C. Wallis,
Robert Boots,
Carl M. J. Kirkpatrick,
Jeffrey Lipman,
Jason A. Roberts
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dku413
Subject(s) - meropenem , pharmacokinetics , volume of distribution , trough concentration , microdialysis , medicine , interstitial fluid , pharmacodynamics , urology , pharmacology , chemistry , anesthesia , antibiotics , biochemistry , antibiotic resistance , central nervous system
To describe the interstitial fluid (ISF) and plasma pharmacokinetics of meropenem in patients on continuous venovenous haemodiafiltration (CVVHDF).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom